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Affects Collagen Deposition in Non-infarcted Myocardium During Remodeling after Coronary Artery Ligation in the
Rat. Journal of Molecular and Cellular Cardiology (1995) 27, 2483±2494. Low-dose aspirin (acetylsalicylic acid; ASA),
inhibiting platelet thromboxane production in favor of endothelium formation of prostaglandins, is successfully used
as primary or secondary prophylaxis against myocardial infarction. Although prognosis may be improved, effects of
long-term ASA treatment on wound healing and cardiac remodeling are not well understood. The aim of the present
study was to mimic the clinical situation by inducing myocardial infarction in low-dose ASA (25 mg/kg/day, i.p.)
pretreated rats, and to determine effects on plasma eicosanoid levels, cardiac hypertrophy and collagen deposition,
and left ventricular function during continued ASA treatment. The effects of this dose were veri®ed to selectively
inhibit platelet thromboxane production, and lower plasma levels of thromboxane, but did not affect plasma levels
of prostacyclin and prostaglandin E2 during the acute in¯ammatory stage following myocardial infarction. As
measured by heart dry weight/body weight, cardiac hypertrophy was not affected by ASA treatment. However,
interstitial ®brosis in the spared myocardium as well as perivascular ®brosis, associated with infarction-induced
cardiac remodeling, were affected by ASA treatment. Replacement ®brosis in the infarct itself, considered as rep-
resenting wound healing, was not signi®cantly in¯uenced by ASA treatment. Wall thinning following infarction
was not aggravated, nor did treatment in¯uence left ventricular cavity diameter in a relaxed state. Results from in
vitro left ventricular function measurements showed no effects on left ventricular peak velocity of contraction or
relaxation after ASA treatment. In conclusion, although low-dose ASA may not be expected to have anti-in-
¯ammatory action, it did in¯uence post-infarct cardiac remodeling by affecting interstitial and perivascular ®brosis.
ASA treatment did not have effects on in vitro left ventricular dysfunction.  1995 Academic Press Limited
K W: Aspirin; Collagen; Infarction; Left ventricular function; Prostaglandins; Remodeling.
favor of anti-aggregatory and vasodilator prosta-Introduction
glandins (Patrignani et al., 1982; Coller, 1991).
ASA improves prognosis and reduces the chanceLow-dose aspirin (acetylsalicylic acid, ASA) treat-
ment is used in coronary artery disease as primary of re-infarction after myocardial infarction (ISIS-2
Collaborative Group, 1988), and this effect can beor secondary prophylaxis against myocardial in-
farction, as it reduces platelet production of pro- attributed to its anti-platelet action (Antiplatelet
Trialists' Collaboration, 1988).aggregatory and vasoconstrictor thromboxane in
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At higher doses, ASA can also exert anti- Validation of the used dose of aspirin
in¯ammatory activity by interference with the
synthesis of prostaglandins. Anti-in¯ammatory To con®rm the selectivity of chronic aspirin treat-
ment as inhibiting platelet versus vascular cyclo-treatment with corticosteroids and non-steroid
anti-in¯ammatory drugs (NSAIDs) has been shown oxygenase activity, a separate group of rats was
treated with either ASA 25 mg/kg body weight (n=to retard collagen deposition and to cause infarct
thinning (Bulkley and Roberts, 1974; Kloner et 6) (based on pilot short-term dose-®nding studies)
or saline (n=6) as daily i.p. injection. Following 3al., 1978; Brown et al., 1983; Hammerman et
al., 1983a,b; Mannisi et al., 1987; Vivaldi et al., weeks of treatment, blood was sampled by heart
puncture under pentobarbital (60 mg/kg) an-1987; Jugdutt and Basualdo, 1989). These studies
focused on the replacement ®brosis that results esthesia, 24 h after the last dose of ASA. Native
blood (1 ml) was allowed to clot in a Vacutainerin scar formation, whereas effects on interstitial
®brosis that occurs in remote, non-infarcted areas glass tube containing SST Gel and Clot Activator
(Becton Dickinson, Meylan Cedex, France) at room(van Krimpen et al., 1991) are still unknown.
Moreover, whether scar formation and cardiac temperature for 30 min. Serum was separated by
centrifugation and, after Sep Pak (Millipore, Milford,®brosis in spared myocardium would be affected
in patients pretreated followed by continued treat- USA) extraction, stored at−20°C in methanol until
assayed for thromboxane B2 (TxB2) produced.ment with low-dose ASA, which seems to be
devoid of anti-in¯ammatory action, remains to be A 2 mm-long segment was isolated from the
thoracic aorta. The segments were incubated atdetermined.
The present study was carried out to address this 37°C for 10 min in 200 ll of Krebs±Henseleit buffer
containing 25 l arachidonic acid (Supelco, Belle-question in a rat model of myocardial infarction
(Fishbein et al., 1978). A dose of ASA that inhibits fonte). The rings were removed and weighed, and
the supernatant passed through Sep Pak ®lters andthromboxane production from platelets but does
not interfere with prostacyclin production from stored at −20°C in methanol until assayed for 6-
keto-PGF1a generation, which was expressed as ng/endothelial cells, was carefully selected as a treat-
ment re¯ecting the aims of low-dose aspirin treat- mg wet tissue of aortic segment.
ment in man. Plasma eicosanoid levels were
evaluated at different time points. The effects on
interstitial and perivascular ®brosis in spared myo-
cardium, on replacement ®brosis in the infarcted
area were investigated, as well as on cardiac re- Surgical preparation
modeling parameters and left ventricular function
in vitro. Under pentobarbital (60 mg/kg, i.p.) anesthesia, a
PE-10 catheter ®lled with heparinized saline (50
IU/ml) was introduced into the thoracic aorta via
the left carotid artery. The catheter was guided
subcutaneously to the neck, where it was ®xed
and exteriorized. Left anterior descending coronaryMethods and Materials
artery ligation was performed as described in detail
elsewhere (Fishbein et al., 1978; Pfeffer et al., 1979;Male, Wistar rats (270±320 g, Harlan Zeist, The
Netherlands) were used in this study. Saline or ASA Schoemaker et al., 1991). Brie¯y, after the trachea
was intubated, an incision was made in the skin25 mg/kg (lysine-acetylsalicylic acid, AspeÂgic, Lo-
rex B.V., Maarssen, The Netherlands) dissolved in overlying the fourth intercostal space, while the
overlying muscles were separated and kept aside.saline was administered as daily i.p. injections of
1 ml/kg, starting 2 days before surgery, and the The animals were put on positive pressure vent-
ilation (frequency 65/min, tidal volume 3 ml), andtreatment continued until the end of the ex-
periment, at 8, 14 or 21 days after surgery. The the thoracic cavity was opened by cutting the
intercostal muscles. The heart was left in situ andinjections were administered at the same time each
day except on the day of surgery, when the animals a 6-0 silk suture was looped under the left coronary
artery near the origin of the pulmonary artery. Thewere injected immediately after the operation. Rats
were housed at a 12 h light/dark cycle with stand- suture was tied except in sham operation. Ribs were
pulled together with 3-0 silk. Subsequently, theard rat chow and water available ad libitum. The
experiments were approved by the University ethics muscles were returned to their normal position,
and the skin was sutured.committee for the use of experimental animals.
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Blood sampling and measurement of eicosanoids to stabilize for at least 20 min. Left ventricular
pressure tracings were recorded at high paper speed
On four occasions, 1 ml blood was sampled using (100 mm/s) for graphical determination of positive
and negative dP/dtmax. At the end of the experiment,syringes ®lled with 10 ll 0.1  disodium ethy-
lenedinitrilotetra-acetic acid (EDTA): immediately hearts were arrested in diastole with a 1  KCl
injection into the perfusing ¯uid, and prepared forafter implanting the aortic catheter, but before
opening the thoracic cavity (day 0), 1 day after measurement of infarct size.
surgery, and 8 and 21 days after surgery, when it
was obtained by aortic puncture. Day 1 was chosen
as a point in time representative of acute in- Infarct size measurement
¯ammation following infarction and day 8 because
it represents chronic in¯ammation, just after peak Large vessels and atria were removed from the
heart, and the right and left ventricles were sep-in®ltration of chronic in¯ammatory cells, and day
21 because in¯ammation has waned (Fishbein et arated and weighed. The left ventricle was quickly
frozen (−80°C) and cut into slices of 1 mm fromal., 1978).
After centrifugation, the plasma was passed apex to base. The slices were stained with nitro
blue tetrazolium (NBT) according to LepraÂn et al.through Sep Pak C18 cartridges (Waters Ass., USA)
and eluted with methanol. Samples were stored at (1983). Brie¯y, the slices were incubated in 1 mg/
ml NBT in 0.1  SoÈrensen phosphate buffer (pH=−20°C in methanol. Because of the instability of
prostacyclin and thromboxane in biological ¯uids, 7.4) at 37°C for 15 min, and subsequently put in
cold saline (0°C). This procedure stains all tissuetheir stabile metabolites, 6-keto-prostaglandin F1a
(6-keto-PGF1a) and TxB2, respectively, as well as that was vital at the time of death, so provides no
information about the area at risk. Colour picturesprostaglandin E2 (PGE2), were measured using
radioimmunoassay (antibodies: Advanced Mag- were taken from the slices, and infarct size was
determined by planimetry, described in detail else-netics, USA; Standards: Sigma, USA) as described
in detail by Zijlstra et al. (1992). To allow com- where (Schoemaker et al., 1991). Infarct size was
expressed as a percentage of left ventricular cir-parison of eicosanoid levels between the three ex-
perimental groups, samples from the same time cumference, calculated as the average of infarct
size of endocardial and epicardial surfaces of allpoint were assayed together.
slices. Minimal scar thickness as well as thickness
of the mid-interventricular septum was measured
in all slices containing transmural infarction. LeftMeasurement of left ventricular function
ventricular cavity diameter in an undistended state
was estimated from mean endocardial cir-Under pentobarbital anesthesia, the heart was rap-
idly excised and mounted for perfusion with an cumference. Thinning ratio was calculated by di-
viding the scar thickness by the thickness of theoxygenated modi®ed Krebs±Henseleit buffer (Com-
position in m: NaCl 125, KCl 4.7, CaCl2 1.35, interventricular septum. Left ventricular cavity dia-
meter to mean wall thickness ratio was calculatedNaHCO3 20, NaH2PO4 0.4, MgCl2 1.0, D-glucose 10;
pH=7.4; 37°C) at a constant pressure of 85 mmHg, as an index of structural left ventricular dilation
(Vogt et al., 1987). Dry weights were determinedusing the Langendorff technique. Heart rate was
kept constant at 300 beats/min by pacing with a after drying the tissues for 3 days at 37°C.
Grass stimulator (Grass Medical Instruments,
Quincy, MA, USA). A water-®lled, latex balloon was
inserted into the left ventricle via the left atrium, Measurement of collagen content
and connected to a pressure transducer (Viggo-
Spectramed, Oxnard, USA). Coronary ¯ow was At 2 weeks after surgery, when a plateau in collagen
content is reached in infarcted hearts (van Krimpen,measured by an in-line ¯ow probe (Transonic Sys-
tems, Ithaca, NY, USA) placed in the tubing just 1991), the amount of interstitial and perivascular
collagen was measured in a separate group of rats,before the aorta to monitor the ¯ow of buffer passing
through the probe just before entering the coronary using the method as described previously (Brilla et
al., 1991; Smits et al., 1992). Brie¯y, the coronaryarteries. Left ventricular pressure and coronary ¯ow
were recorded with a Grass 6B Polygraph (Grass arteries were perfused with saline (Langendorff),
followed by perfusion-®xation with 3.6% phos-Medical Instruments, MA, USA). Left ventricular
end-diastolic pressure was set to 5 mmHg by ad- phate-buffered formaldehyde. The atria and large
vessels were removed, the ventricles weighed andjusting the balloon volume and hearts were allowed
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cut into four slices from apex to base. These slices Results
were ®xed in formaldehyde for at least 24 h. After
®xation, the slices were dehydrated and paraf®n On average, surgery-related mortality was 32%
(shams 21%, saline-treated infarctions 37%, as-embedded. Deparaf®nized 5 lm thick sections were
incubated for 5 min with 0.2% (wt/vol) aqueous pirin-treated infarctions 41%), and occurred mainly
during the ®rst 24 h after surgery. After exclusionphosphomolybdic acid, and subsequently incubated
for 45 min with 0.1% Sirius Red F3BA (C.I.35780, of data from three aspirin-treated and ®ve saline-
treated infarcted animals because of infarct sizesPolysciences Inc., Northampton, UK) in saturated
aqueous picric acid, washed for 2 min with 0.01  smaller than 20%, infarct sizes were comparable
in the saline-treated and aspirin-treated infarctionHCl, dehydrated, and mounted with Entellan
(Merck, Darmstadt, Germany). Distribution of col- groups (Table 1). All infarctions were transmural
and were located in the lateral (free) wall of thelagen ®bers in sections examined with normal and
with polarized light was similar, validating the left ventricle.
quanti®cation of collagen with normal light (Fig.
1). In the interventricular septum, as well as in the
right ventricle, interstitial collagen was determined
as the picrosirius red positive area in 40 high
power ®elds per ventricle per heart. These areas of Validation of the used dose of aspirin
myocardium did not show signs of replacement
®brosis following focal necrosis. Thus, we measured Generation of 6-keto-PGF1a by aortic endothelium
stimulated by arachidonic acid (1.35±0.22 ng/mginterstitial ®brosis as the increase of collagen vol-
ume in the interstitium between vital myocytes wet weight in saline-treated rats) was not affected
by 3 weeks of ASA treatment (1.32±0.21 ng/(Fig. 1). In addition, perivascular collagen of six to
10 septal resistance arteries (diameter ap- mg wet weight). Production of TxB2 from platelets
during blood clotting was effectively attenuated byproximately 100 lm) was measured (Fig. 2). The
perivascular picrosirius red positive area was cor- ASA therapy (1.91±0.53 ng/ml serum v
5.88±0.55 ng/ml serum). Consequently, 6-keto-rected for luminal area of the vessel (Brilla et al.,
1991). In order to evaluate effects on wound heal- PGF1a to TxB2 ratio with ASA treatment
(1.07±0.30) was signi®cantly increased compareding in infarcted hearts, the picrosirius red positive
area was also determined in the central part of the to saline-treated animals 0.24±0.03).
infarct itself.
Plasma eicosanoid levels (Fig. 3)
Data analysis
TxB2 levels were signi®cantly lowered by ASA treat-
ment at all time points except at day 8, when noResults comprise data obtained from six to 12
animals per group. Data are expressed as group statistical signi®cance was reached (P=0.07). TxB2
levels appeared to be higher at 21 days comparedmeans±... unless indicated otherwise. Rats in
the sham group had measured infarct sizes of 0%. to the other time points, but these samples were
assayed separately. 6-Keto-PGF1a levels were sig-Data from rats with measured infarct sizes less than
20% were excluded from analysis, because these ni®cantly decreased by ASA treatment at day 0
and 21, but not during in¯ammatory stimulation,infarcts are hemodynamically fully compensated
(Schoemaker et al., 1991). Only eicosanoid meas- at day 1 and 8. This resulted in a comparable
presurgical 6-keto-PGF1a to TxB2 ratio in ASA-urements of animals that survived the complete
protocol were used. Because plasma eicosanoid and saline-treated rats (3.5±1.1 and 3.1±1.0,
respectively), whereas this ratio was signi®cantlylevels did not show a normal distribution, median
values ±95% con®dence intervals are quoted, and increased in ASA-treated animals, during acute
in¯ammation, at day 1 (16.4±4.9 v 5.0±1.7).non-parametric data analysis was performed, using
the Kruskal±Wallis test. Morphological and func- The ratio returned to presurgical levels at day
8 (3.5±0.7 v 2.5±0.6). PGE2 levels were nevertional data were analysed using one-way analysis
of variance (ANOVA), followed by a post hoc affected by ASA treatment, although a tendency
towards inhibition might be present after 3 weekst-test (Wallenstein et al., 1980). Differences were
considered statistically signi®cant if P<0.05. of treatment.
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Figure 1 Picrosirius red stained sections of interventricular septum of hearts from a/b: a sham-operated rat (a with
normal light and b with polarized light), c/d: a saline-treated rat after infarction of the left ventricular free wall (c with
normal light and d with polarized light), e/f: an ASA-treated rat after infarction of the left ventricular free wall (e with
normal light and f with polarized light) (original magni®cation: ×62.5).
Left ventricular morphology and function increased. This was the result of an increased left
ventricular cavity diameter (3.2±0.2 v
Heart wet weight was signi®cantly increased at 2.4±0.1 mm) and a decreased wall thickness
(3.2±0.1 v 3.7±0.1 mm) at an unchanged outer8 days after myocardial infarction, which was
mainly attributable to the left ventricle. This diameter (9.7±0.2 mm for both groups), at 21
days. These parameters were comparable in heartsobservation was even more pronounced in in-
farcted hearts from ASA-treated rats. However, from saline- and ASA-treated animals. Scar thick-
ness did not differ between untreated and ASA-for dry weights no differences between the ex-
perimental groups were present. Heart dry weight treated rats (1.1±0.1 v 1.2±0.1 mm at 8 days,
and 1.3±0.1 v 1.5±0.2 mm at 21 days), nor wasto body weight ratios did not differ between the
groups (Table 1). septal thickness altered by ASA therapy (4.2±0.2
v 4.3±0.1 mm at 8 days, and 4.3±0.2 vThe ratio of left ventricular cavity diameter in a
relaxed state to wall thickness was signi®cantly 4.2±0.3 mm at 21 days, in untreated and ASA-
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Figure 2 Picrosirius red stained sections of interventricular septum containing resistance arteries, from a: a sham-
operated rat, b: a saline-treated rat after infarction of the left ventricular free wall, c: an ASA-treated rat after infarction
of the left ventricular free wall (original magni®cation: ×62.5).
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Table 1 Characteristics of hearts 8 days and 3 weeks after surgery
Sham MI MI+ASA
n Day 8 12 12 11Day 21 11 10 8
Infarct size (%) Day 8 0 41±2 43±3Day 21 0 37±1 39±3
Heart wet weight (mg) Day 8 792±24 954±43∗ 1046±40∗Day 21 978±35 928±22 928±23
Wet weight/BW (mg/g) Day 8 2.81±0.14 3.74±0.30∗ 4.11±0.24∗Day 21 2.54±0.10 2.52±0.06 2.60±0.05
Heart dry weight (mg) Day 8 165±3 154±5 157±4Day 21 198±7 179±4 181±5
Dry weight/BW (mg/g) Day 8 0.58±0.02 0.59±0.03 0.61±0.02Day 21 0.51±0.01 0.48±0.01 0.51±0.01
LV thinning ratio Day 8 0.28±0.02 0.30±0.02Day 21 0.31±0.04 0.39±0.10
LV diameter/WT Day 8 0.46±0.04 1.18±0.09∗ 1.07±0.07∗Day 21 0.66±0.04 1.03±0.10∗ 0.91±0.12∗
MI, myocardial infarction; MI+ASA, ASA-treated myocardial infarction; wet weight/BW, heart wet weight/body
weight; dry weight/BW, heart dry weight/body weight; LV, left ventricle; thinning ratio, minimal scar thickness
to midseptal thickness ratio; LV diameter/WT, left ventricle inner diameter/wall thickness.
∗: Signi®cantly different from sham values.
treated rats, respectively). Thus, thinning ratio was after ASA treatment (Figs 1 and 4). Also in right
ventricular myocardium, infarcted hearts showednot in¯uenced by ASA treatment (Table 1).
In vitro left ventricular dysfunction of infarcted a higher interstitial collagen content, which was
slightly but insigni®cantly reduced by ASA treat-hearts became evident from a depressed peak ve-
locity of contraction and relaxation, demonstrated ment (Fig. 4).
Perivascular collagen of resistance arteries in theby a signi®cantly depressed peak +(dP/dt) and
−(dP/dt ). ASA treatment delayed the development interventricular septum was signi®cantly increased
after infarction (0.96±0.09 v 0.63±0.09 pi-of left chamber dysfunction; contractility and re-
laxation were not signi®cantly depressed until 3 crosirius red positive area/luminal area). ASA treat-
ment signi®cantly affected this collagen depositionweeks after infarction. A similar tendency, though
less pronounced, could be seen for systolic pressure (0.71±0.05, P=0.04) (Fig. 2).
developed during Langendorff perfusion. Coronary
¯ow in infarcted hearts was not decreased compared
to sham values. However, at 8 days after surgery,
coronary ¯ow corrected for wet cardiac tissue
Discussionweight, but not for dry weight, was signi®cantly
decreased in infarcted hearts after ASA treatment
ASA treatment and eicosanoid pro®le(Table 2).
In the primary and secondary prophylaxis of myo-
cardial infarction low-dose aspirin is successfully
used as anti-platelet therapy because it inhibitsCollagen deposition in infarcted and non-infarcted
myocardium (Figs 1, 2 and 4) platelet production of thromboxane in favor of endo-
thelium formation of prostaglandins. In this study,
In the infarcted area itself, 56.0±3.3% of total ®rstly, we evaluated the effects of ASA treatment
in normal healthy animals with regard to platelettissue area was found picrosirius red positive, which
was not signi®cantly in¯uenced by ASA treatment and vascular endothelium cyclo-oxygenase po-
tential to generate thromboxane and prostacyclin,(49.4±1.0%). Non-infarcted, interventricular sep-
tum showed a considerably higher content of pi- respectively. This is important because inter-species
differences in sensitivity and metabolism make dosecrosirius red positive material after coronary artery
ligation than corresponding areas in hearts from extrapolation from animal to man on a body weight
basis questionable. Corresponding to the rationalesham operated rats, which was almost normalized
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(Gambino et al., 1988). The site of production of
plasma prostacyclin may not be limited to vascular
endothelium (Mehta et al., 1985; Vergara-Dauden
et al., 1985; Weber et al., 1989).
Prostacyclin levels during the in¯ammatory stage
(day 1 and 8) were not affected by ASA treatment.
Although in¯ammation did not result in higher
plasma concentrations of prostacyclin, there may
be a greater proportion of total release into plasma
attributable to the inducible cyclooxygenase-2
(COX-2) at the expense of the constitutional cyclo-
oxygenase-1 (COX-1) (Vane et al., 1994). The COX-
2 isoform is less sensitive to inactivation by ASA
(Mitchell et al., 1993). Plasma eicosanoid levels
during this in¯ammatory stage showed a high in-
teranimal variability (with no Normal distribution).
Since variation of plasma eicosanoid levels rather
than absolute values were increased at day 1 com-
pared to day 0, and no differences were observed
between sham and infarcted rats, we concluded
that the surgical procedure rather than the in-
farction was responsible for the variability in plasma
levels and may represent individual in¯ammatory
responses to surgery. The variation may decline
with time, indicative for acute and later waning
in¯ammatory response.
Left ventricle morphology and in vitro function
A major ®nding in the present study is that low-
dose ASA therapy affected collagen build-up in
spared myocardium after infarction. High-dose ASA
Day 0
n
g/
m
l p
la
sm
a
10
1
0.1
*
*
TxB2
Day 1 Day 8 Day 21
Day 0
n
g/
m
l p
la
sm
a
10
1
0.1
*
6-keto-PGF1a
Day 1 Day 8 Day 21
Day 0
n
g/
m
l p
la
sm
a
10
1
0.1
PGE2
Day 1 Day 8 Day 21
*
*
treatment, providing plasma levels associated with
Figure 3 Plasma eicosanoid levels (ng/ml) at different anti-in¯ammatory action in humans, has been
time points following surgery. Median values and 95% shown to inhibit both the synthesis and degradation
con®dence intervals are shown. Open bars: sham (n= of collagen in rat skin (Solheim et al., 1986a), as9±12); Gray bars: saline-treated infarction (n=10±12);
well as the synthesis of collagen in rat bone (SolheimHatched bars: ASA-treated infarction (n=8±11).
et al., 1986b). Numerous studies have reported on∗:P<0.05 v saline-treated rats.
the effects of steroids and NSAIDs on scar thickness
and collagen build-up in the infarcted area (Bulkley
and Roberts, 1974; Kloner et al., 1978; Brown etbehind the clinical use in man, chronic ASA treat-
ment did not affect vascular endothelium cyclo- al., 1983; Hammerman et al., 1983a,b; Mannisi et
al., 1987; Vivaldi et al., 1987). Moreover, prosta-oxygenase, while TxB2 generation by platelets
during blood clotting was effectively blocked. How- glandins have been implicated in the regulation of
®broblast proliferation (Otto et al., 1982). Therefore,ever, measurements in plasma during our ex-
periments using the same dose of ASA showed some it seems rational to link the effects of ASA therapy
to its anti-in¯ammatory action. However, in theinterference with prostaglandin synthesis as well,
as indicated from a decrease of prostacyclin levels present study, ASA treatment did not affect prosta-
glandin levels during the in¯ammatory phase afterat those time points that were not associated with
the in¯ammatory response to infarction. This dis- infarction. Secondly, ®brosis in the spared myo-
cardium, remote from the infarct, rather than increpancy could be explained by the fact that the
dose of ASA, that selectively inhibits thromboxane the infarcted area itself was affected; scar thinning
and scar collagen content were not signi®cantlysynthesis, was evaluated in vitro only in those
tissues in which the major production was expected altered. On the other hand, in¯ammation may not
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Table 2 Functional parameters during Langendorff perfusion
Sham MI MI+ASA
n Day 8 9 9 8Day 21 11 10 8
Systolic pressure (mmHg) Day 8 68±4 57±6 64±8Day 21 75±5 51±4∗ 49±4∗
+(dP/dt )max (mmHg/s)
Day 8 5237±846 2972±548∗ 3744±743
Day 21 6967±806 3162±332∗ 3165±557∗
−(dP/dt )max (mmHg/s)
Day 8 1338±95 991±98∗ 1136±133
Day 21 1282±96 885±62∗ 831±75∗
Coronary ¯ow (ml/min) Day 8 10.0±1.3 8.6±0.6 8.8±0.9Day 21 11.3±0.7 10.5±0.6 11.0±1.4
CF/wet weight (ml/min/g) Day 8 13.0±1.7 9.6±0.9 8.6±0.8∗Day 21 11.6±0.6 11.1±0.8 11.8±1.4
MI, myocardial infarction; MI+ASA, ASA-treated myocardial infarction; systolic pressure, left ventricular systolic
pressure; +(dP/dt )max and −(dP/dt )max: maximum velocity of pressure rise and decline, respectively. CF/wet weight:
coronary ¯ow per g of wet cardiac tissue.
∗: Signi®cantly different from sham values.
be limited to the infarcted area itself (Sulpice et different control mechanisms. Corday et al. (1975)
pointed out that in dogs, in an experimental modelal., 1994). The observation that at 8 days after
infarction, when cardiac edema is known to be over of myocardial infarction, replacement ®brosis was
not limited to the infarcted area, but was alsoits maximum (Fishbein et al., 1978), increased
tissue water content was more pronounced with present in areas remote from the infarct, as a result
of focal necrosis. Because we have not observedASA therapy, suggests still some interference with
local in¯ammatory response to infarction. Other focal necrosis in the sections of spared myocardium
analysed for ®brosis in the rat coronary arterypossibilities include a role for thromboxane, direct
or indirect in the prevention of release of platelet- ligation model, this indicates that we indeed quan-
ti®ed interstitial ®brosis in non-infarcted areas, andderived growth factor (Vissinger et al., 1993; Lanas
et al., 1994). Finally, effects of medication unrelated that replacement ®brosis could be considered limited
to the infarcted area itself.to inactivation of cyclo-oxygenase, for example by
metabolites of ASA (Haynes et al., 1993), cannot In the present study, only total collagen content
was measured. Collagen type, cross-linking, ®berbe excluded.
Another important aspect of the effect of ASA is organization and ®ber thickness could also alter
the mechanical properties of the myocardium. Wethat the prevention of collagen build-up in non-
infarcted tissue after infarction did not result in a cannot exclude that not only the quantity, but also
the characteristics of the collagen were affected byfurther increase of left ventricular cavity diameter
in a relaxed state. Diastolic pressure±volume curves ASA treatment. For example, ASA treated hearts
could have a higher proportion of thin collagenin infarcted hearts were not altered by ASA treat-
ment (data not shown), indicating that also during ®laments, as is also suggested by the pho-
tomicrographs shown in Figure 1.distension by pressures that are physiological dur-
ing diastole, left ventricular dilation was not ag- Since large myocardial infarction did not decrease
heart dry weight to body weight ratios, hypertrophygravated by ASA treatment. Therefore, it is likely
that ASA treatment did not aggravate the initial of spared myocardium is indicated. Although we
have not actually measured myocyte dimensions,process of breakdown of pre-existing collagen ®bres
correlating with post-infarct dilation (Whittaker et comparable heart dry weights make it unlikely
that ASA treatment would reduce cardiomyocyteal., 1991). Likewise, the slightly lower collagen
content of the infarcted tissue did not result in hypertrophy in addition to collagen content, as is
the case with ACE-inhibitor and angiotensin IIfurther thinning of this area, which has been de-
scribed with steroids and NSAIDs (Brown et al., blocker therapy (van Krimpen et al., 1991; Smits
et al., 1992). There was no signi®cant effect of ASA1983; Hammerman et al., 1983a,b; Mannisi et al.,
1987). An effect of ASA treatment on interstitial therapy on in vitro left ventricular performance. If
anything, there may be a tendency to delay the®brosis of spared myocardium, but not on re-
placement ®brosis of infarcted tissue, suggests that onset of left ventricular dysfunction. After ASA
treatment, the signi®cant depression of peakthese are indeed two different processes governed by
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®brosis at 14 days makes it unlikely that the treat-
ment effect would be absent at the other time points
during the healing period. Moreover, retardation of
the healing period by ASA, implying a temporary
nature of the observed treatment effects, is unlikely
because of the lack of effect on collagen deposition in
the infarcted area. However, the effect on interstitial
®brosis of remodeled, spared hypertrophic myo-
cardium by ASA treatment, did not result in an
altered diastolic pressure±volume relationship of the
whole left ventricle (data not shown). Thus, at
present, the consequence of pharmacological in-
terference with collagen synthesis during re-
modeling after infarction, for cardiac function,
remain unclear.
In conclusion, the results from the present study
show that 25 mg/kg/day ASA, which causes a
more marked inhibition of thromboxane than of
prostaglandin synthesis in rats, seems phar-
macologically equivalent to the use of chronic low-
dose aspirin treatment in patients. This dose affected
interstitial and perivascular ®brosis in the spared
myocardium, while leaving wound healing, meas-
ured as scarring and thinning of the infarcted area,
and compensatory hypertrophy relatively un-
affected. Besides a possible delay in the development,
aspirin treatment had no effect on ®nal in vitro left
ventricular dysfunction.
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